Fig. 3From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysisForest plot of hazard ratio of overall survival using a random-effects model of hepatocellular carcinomaBack to article page